XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

U.S. STOCKS Chewy, Abercrombie & Fitch, Kohl's



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Chewy, Abercrombie & Fitch, Kohl's</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street's main indexes were set for a muted open on Wednesday ahead of Nvidia's earnings report, with focus squarely on if the recent bull market rally that was led by the AI chip firm and other tech-related shares can be sustained. .N


At 9:01 ET, Dow e-minis 1YMc1 were down 0.07% at 41,329. S&P 500 e-minis ESc1 were down 0.05% at 5,641.75, while Nasdaq 100 e-minis NQc1 were down 0.08% at 19,639.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Brookfield Business Partners LP BBU.N, up 13.2%
** Allurion Technologies ALUR.N, up 5.9%
** Perfect Corp PERF.N, up 5.9%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Abercrombie & Fitch Co ANF.N, down 9.4%
** Foot Locker Inc FL.N, down 8.7%
** Pvh Corp PVH.N, down 8.4%

The top Nasdaq percentage gainer premarket .PRPG.O:
** Bolt Projects Holdings Inc BSLK.O, up 105.3%

The top two Nasdaq percentage losers premarket .PRPL.O:
** Agape Atp Corp ATPC.O, down 17.7%
** Arbuthnot Banking Group PLC ARBB.O, down 16.8%


** SentinelOne Inc S.N: up 3.8% premarket
BUZZ - Climbs as higher client spending prompts upbeat forecast nL4N3KF0MD


** nCino Inc NCNO.O: down 14.1% premarket
BUZZ - Slides after unchanged annual revenue forecast nL4N3KF0P0


** Coinbase Global Inc COIN.O: down 1.9% premarket
** Riot Platforms Inc RIOT.O: down 1.4% premarket
** Marathon Digital Holdings Inc MARA.O: down 2.4% premarket
** Hut 8 Mining Corp HUT.O: down 2.0% premarket
BUZZ - Crypto stocks fall in tandem with bitcoin nL4N3KF0PZ


** Newmont Corp NEM.N: down 1.2% premarket
** Barrick Gold Corp GOLD.N: down 1.5% premarket
** Gold Fields Ltd GFI.N: down 2.7% premarket
** AngloGold Ashanti Ltd AU.N: down 3.6% premarket
BUZZ - Gold miners decline after bullion falls 1% nL4N3KF11H


** PVH Corp PVH.N: down 8.4% premarket
BUZZ - Drops after downbeat Q3 forecasts nL4N3KF0ST


** Semtech Corp SMTC.O: up 6.3% premarket
BUZZ - Gains on upbeat forecast, Q2 results beat nL4N3KF0TT


** Ambarella Inc AMBA.O: up 20.1% premarket
BUZZ - Soars after Q3 revenue forecast above estimates nL4N3KF0S4


** Foot Locker Inc FL.N: down 8.7% premarket
BUZZ - Drops as co posts wider Q2 loss, reaffirms annual forecasts nL4N3KF0UX


** Kohl's Corp KSS.N: up 1.3% premarket
BUZZ - Jumps on raising annual profit forecast nL4N3KF0WG


** Patterson Companies Inc PDCO.O: down 8.5% premarket
BUZZ - Tumbles on Q1 profit miss nL4N3KF0XX


** Nanobiotix SA NBTX.O: up 4.3% premarket
BUZZ - Guggenheim initiates Nanobiotix coverage with 'buy', shares rise nL4N3KF0XN


** Bath & Body Works Inc BBWI.N: down 3.5% premarket
BUZZ - Down after annual profit, sales forecast cut nL4N3KF0XF


** Chewy Inc CHWY.N: up 2.4% premarket
BUZZ - Rises on Q2 profit beat nL4N3KF0Y6


** Starwood Property Trust Inc STWD.N: up 0.6% premarket
BUZZ - Raymond James raises Starwood Property Trust PT nL4N3JV1OA


** J.M. Smucker Co SJM.N: down 4.3% premarket
BUZZ - Down on trimming annual sales, profit forecasts nL4N3KF0ZH


** Abercrombie & Fitch Co ANF.N: down 9.4% premarket
BUZZ - Pares YTD gains after Q2 results nL4N3KF0ZS


** 23andMe Holdings Co ME.O: up 6.8% premarket
BUZZ - Unit to offer GLP-1 medication through weight loss program, shares rise nL4N3KF106


** Maravai LifeSciences Holdings Inc MRVI.O: up 3.0% premarket
BUZZ - Climbs on collaboration to launch DNA concentration testing kit nL4N3KF11L


** Exxon Mobil Corp XOM.N: down 0.4% premarket
** Chevron Corp CVX.N: down 0.4% premarket
** Marathon Oil Corp MRO.N: down 0.6% premarket
** SM Energy Co SM.N: down 1.1% premarket
BUZZ - Oil companies fall as demand concerns offset supply risks nL4N3KF117


** Ocugen Inc OCGN.O: up 1.5% premarket
BUZZ - Rises on completing patient dosing in early-stage gene therapy trial nL4N3KF0XG


(Compiled by Rajarshi Roy and Pooja Menon in Bengaluru)

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.